Early Diagnosis of Primary Nonfunction and Indication for Reoperation After Liver Transplantation

被引:102
|
作者
Lock, Johan Friso [1 ]
Schwabauer, Eugen [1 ]
Martus, Peter [2 ]
Videv, Nikolay [1 ]
Pratschke, Johann [1 ]
Malinowski, Maciej [1 ]
Neuhaus, Peter [1 ]
Stockmann, Martin [1 ]
机构
[1] Charite, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany
[2] Charite, Inst Biostat & Clin Epidemiol, D-13353 Berlin, Germany
关键词
GRAFT FUNCTION; AMINOPYRINE; DYSFUNCTION; DEFINITION;
D O I
10.1002/lt.21973
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Initial graft function is a major factor influencing the clinical outcome after liver transplantation (LTX), but a reliable method for assessing and predicting graft dysfunction directly after LTX is not available. Ninety-nine patients undergoing deceased-donor LTX were studied in a prospective pilot study to evaluate the LiMAx test, the indocyanine green test, and conventional biochemical parameters with respect to their sensitivity and prognostic power for the diagnosis of initial graft dysfunction. Patients suffering from initial graft dysfunction (defined as technical complications or primary nonfunction (n = 8)) had significantly decreased LiMAx readouts (43 +/- 18 versus 184 98 pg/kg/hour, P < 0.001) immediately after LTX. Univariate analysis also showed significant differences for serum bilirubin, ammonia, glutamate dehydrogenase, and the international normalized ratio (P < 0.05), but multivariate analysis revealed LiMAx as the single independent predictor of initial dysfunction (P = 0.008) with an area under the receiver operating characteristic curve (AUROC) of 0.960 (95% confidence interval = 0.921-0.998, P < 0.001). In addition, the diagnosis of primary nonfunction (n = 3) was evaluated with UMAX and aspartate aminotransferase (AST) activity on the first postoperative day. The calculated AUROC values were 0.992 (0.975-1.0, P = 0.004) for LiMAx and 0.967 (0.929-1.0, P = 0.006) for AST By a combination of test results obtained directly after LTX and on the first day, LiMAx indicated primary nonfunction with a sensitivity of 1.0 (0.31-1.0) and a positive predictive value of 1.0 (0.31-1.0), whereas AST classification showed a sensitivity of 0.67 (0.13-0.98) and a positive predictive value of 0.29 (0.05-0.70). In conclusion, the assessment of initial graft function using the LiMAx test might be effective for identifying critical complications that could threaten graft survival within 24 hours after LTX. Liver Transpl 16:172-180, 2010. (C) 2010 AASLD.
引用
收藏
页码:172 / 180
页数:9
相关论文
共 50 条
  • [21] Reoperation in the early period after adult living donor liver transplantation is poor
    Lim, M.
    Rhu, J. S.
    Kim, J. M.
    TRANSPLANTATION, 2019, 103 (08) : 142 - 142
  • [22] EVALUATION OF FACTORS RELATED TO PRIMARY GRAFT DYSFUNCTION AND NONFUNCTION IN THE LIVER TRANSPLANTATION
    Coelho, Gustavo R.
    Vasconcelos, Katia F.
    Valenca, Jose T., Jr.
    Vasconcelos, Joao B.
    Filho, Douglas H.
    Rocha, Tarciso D.
    Viana, Cinthya F.
    Coelho, Clovis R.
    Costa, Paulo E.
    Brasil, Ivelise R.
    Borges, Gleydson C.
    Mesquita, Denissa F.
    Sherenken, Dirk
    Barros, Marcos A.
    Garcia, Jose H.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S181 - S181
  • [23] The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation
    Yoo, HY
    Molmenti, E
    Thuluvath, PJ
    LIVER TRANSPLANTATION, 2003, 9 (01) : 72 - 78
  • [24] Early diagnosis and reoperation in persistent primary hyperparathyroidism
    Walgenbach, S
    Junginger, T
    CHIRURG, 1999, 70 (10): : 1126 - 1130
  • [25] INDICATION FOR REOPERATION AFTER CHOLEDOCHODUODENOSTOMY
    SCHMIDT, HD
    BRUNNER, H
    DANIELS, V
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1980, 352 : 560 - 560
  • [26] PRIMARY GRAFT NONFUNCTION FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION - TREATMENT WITH PROSTACYCLIN
    BRIEGEL, J
    HALLER, M
    ZULKE, C
    KILGER, E
    PRATSCHKE, E
    JAUCH, KW
    BERGER, H
    FORST, H
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (06) : 2693 - 2695
  • [27] Impact of early reoperation on graft survival after liver transplantation: Univariate and multivariate analysis
    Elsabbagh, Ahmed M.
    Girlanda, Raffaele
    Hawksworth, Jason
    Pichert, Matthew D.
    Williams, Cassie
    Pozzi, Agostino
    Kroemer, Alexander
    Nookala, Anupama
    Smith, Coleman
    Matsumoto, Cal S.
    Fishbein, Thomas M.
    CLINICAL TRANSPLANTATION, 2018, 32 (06)
  • [28] PROSTAGLANDIN-E1 FOR PRIMARY NONFUNCTION FOLLOWING LIVER-TRANSPLANTATION
    GREIG, PD
    WOOLF, GM
    ABECASSIS, M
    FORSTER, J
    STRASBERG, SM
    TAYLOR, BR
    SUPERINA, RA
    GLYNN, MFX
    ETTLES, M
    BLENDIS, LM
    LEVY, GA
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (02) : 3360 - 3361
  • [29] Where Is the Maximum Benefit of Everolimus after Liver Transplantation?: Early Or Late Indication
    Bilbao, Itxarone
    Dopazo, Cristina
    Luis Lazaro, Jose
    Castells, Lluis
    Caralt, Mireia
    de la Serna, Sofia
    Charco, Ramon
    LIVER TRANSPLANTATION, 2014, 20 : S171 - S171
  • [30] Complications Requiring Reoperation after Pediatric Liver Transplantation
    Yoeli, D.
    Moffett, J.
    Hosek, K.
    Ackah, R.
    Sigireddi, R.
    Kueht, M.
    Galvan, T.
    Cotton, R.
    Rana, A.
    Mahony, C.
    Goss, J.
    TRANSPLANTATION, 2017, 101 (05) : 261 - 261